Invest in the Infrastructure Powering Africa's Next Healthcare Revolution
West African Health Partners is building a scalable medical infrastructure platform that gives physicians access to modern clinical space, integrated diagnostics, technology, and operational support — starting in Ghana and designed for expansion across West Africa.
Accredited investors only. Verification required.
This investment opportunity is intended exclusively for verified accredited investors pursuant to Rule 506(c) of Regulation D.
A Scalable Platform Addressing a Structural Healthcare Gap
Across West Africa, talented physicians face major barriers to independent medical practice: high startup costs, limited access to modern diagnostic services, fragmented technology, and inadequate clinical infrastructure. WAHP brings these components together in one integrated platform.
Large and growing healthcare demand
Rapid urbanization, population growth, rising healthcare expectations, and expanding private healthcare demand are increasing the need for dependable outpatient infrastructure.
Multiple complementary revenue streams
WAHP is designed to generate revenue through medical co-working leases, diagnostics and laboratory services, technology subscriptions, and corporate or institutional contracts.
Phased, capital-disciplined launch
WAHP will begin with medical co-working infrastructure, expand laboratory operations, and introduce imaging services after validating utilization and operational performance.
Regional replication potential
The initial Ghana location is intended to validate a repeatable model that can later expand to additional Ghanaian and West African urban markets.
Launching in a Market with Demand, Talent, and Regional Reach
WAHP plans to launch in Ghana, where urban growth, physician concentration, increasing demand for private care, and the need for more efficient outpatient infrastructure create a compelling initial market.
$1.21B
Estimated Ghana curative and ancillary healthcare market
WAHP estimate · Ghana MoH 2023
42%
Of Ghana's physicians are concentrated in Accra
WHO Ghana
36.7%
Of Ghana health expenditure occurs in private facilities
Ghana MoH 2023
$214M
Estimated Greater Accra serviceable market
WAHP estimate using Greater Accra population share as a proxy
Greater Accra and Ashanti are major centers of population, clinical activity, and private healthcare demand. WAHP's research also identified persistent limitations in diagnostic availability, private-practice infrastructure, regulatory consistency, and service delivery.
Ghana offers WAHP the opportunity to validate the model in a sophisticated West African healthcare market before expanding selectively into other high-demand cities.
Source:
Ghana Ministry of Health, National Health Accounts 2018–2022; Ghana Statistical Service, 2021 Population and Housing Census.
Diversified Revenue Built Around a Shared Healthcare Platform
WAHP's model is designed to generate recurring and transaction-based revenue from multiple parts of the healthcare delivery chain. Each revenue stream supports the others.
Medical co-working leases
Revenue from equipped consultation rooms, examination rooms, offices, and outpatient suites offered on flexible terms.
Laboratory services
Revenue generated from clinical testing provided directly or through operating partnerships.
Diagnostic imaging
Planned revenue from X-ray, ultrasound, CT, and other imaging services introduced as the facility scales.
Technology subscriptions
Recurring access to scheduling, billing, electronic health records, analytics, and telemedicine capabilities.
Corporate and institutional programs
Workforce health screenings, diagnostics programs, referral partnerships, and potential public-private healthcare initiatives.
Validate First. Scale with Discipline.
WAHP's feasibility work recommends a phased approach with location-sensitive budgeting, resilient infrastructure, qualified staffing, regulatory planning, and careful equipment procurement.
- Phase 1
Medical co-working launch
Launch equipped clinical suites, shared reception and administrative support, and the core technology platform.
- Phase 2
Laboratory integration
Introduce onsite laboratory services to increase provider utility, strengthen referral pathways, and expand revenue per patient interaction.
- Phase 3
Imaging expansion
Add X-ray, ultrasound, and CT capabilities after core utilization and operational workflows have been established.
- Phase 4
Replication
Use performance data from the flagship location to evaluate additional Ghanaian and regional locations.
Phase sequencing reflects management's current plan. Timing is dependent on capital, licensing, construction, and utilization outcomes, and is subject to change. Source: WAHP Final Feasibility Report, Sections 2–7.
Capital-Efficient Entry with Multiple Paths to Revenue
WAHP is using a phased capital strategy to launch its flagship facility, establish core operations and technology, and build the foundation for future laboratory and imaging services.
Management's current financial model projects revenue growth across medical co-working, laboratory, imaging, and corporate programs, with positive EBITDA anticipated after the initial launch period.
Detailed financial projections, unit economics, assumptions, and sensitivity analysis are available to verified accredited investors through the investor data room.
Primary uses of capital include facility lease, construction, equipment and furnishings, technology, legal and regulatory work, marketing, operating cushion, and reserves.
- Forward-Looking Information
Financial projections are forward-looking estimates based on management assumptions. They are not guarantees of future performance. Actual results may differ materially due to operational, regulatory, market, currency, construction, utilization, and financing risks.
- Target Raise
$800,000
Phased capital plan to launch the flagship Greater Accra facility, establish co-working operations, and build the operating base for laboratory and future imaging services.
Detailed projections, including multi-year revenue and EBITDA modelling, are provided behind the investor-access gate to verified accredited investors. Source: WAHP Pitch Deck v12.
How the Capital Will Be Deployed
Capital is allocated across four categories. A full line-item breakdown is available in the investor materials.
Facility and construction
Equipment and technology
Launch and regulatory
Operating cushion and reserves
Where Physician Autonomy Meets Integrated Infrastructure
- Traditional Hospitals
Infrastructure without independence
Provide clinical infrastructure but limited physician independence. Institutional schedules and priorities take precedence over individual clinical judgment.
- Diagnostic Chains
Testing without a practice environment
Provide specific testing services but not a complete practice environment. A physician still needs to source space, staffing, systems, and administration separately.
- WAHP Platform
Designed to combine both
Independent clinics offer autonomy but require significant capital and fragmented operations. WAHP is designed to bring the components together:
- Physician autonomy
- Clinical infrastructure
- Integrated diagnostics
- Shared administrative support
- Technology-enabled operations
WAHP is designed to occupy a differentiated position between traditional hospitals, diagnostic chains, and independently operated clinics.
Help Build the Infrastructure Behind Better Healthcare Delivery
WAHP is preparing a Rule 506(c) offering for verified accredited investors seeking exposure to an early-stage healthcare infrastructure platform.
Register your interest
Share your details and our team will follow up with next steps and verification instructions. This does not create any obligation to invest.
Accredited investors only. Verification required. No financial documents are collected on this website.
- Important Notice
The information on this page is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to purchase securities. Any offering will be made only through definitive offering and subscription documents provided by West African Health Partners and only to persons who are verified as accredited investors pursuant to Rule 506(c) of Regulation D.
An investment in West African Health Partners is speculative, involves a high degree of risk, and may result in the loss of the entire investment. The securities have not been registered under the Securities Act of 1933 or applicable state securities laws, are subject to restrictions on transfer, and may not be readily resold.
Neither the Securities and Exchange Commission nor any state securities regulator has approved or disapproved the securities, passed upon the merits of the investment, or determined the accuracy or completeness of the information presented.
Statements regarding future events, expansion, revenue, profitability, market opportunity, or business performance are forward-looking statements based on current assumptions and are subject to significant risks and uncertainties. Actual results may differ materially.